98 related articles for article (PubMed ID: 6825122)
21. Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma.
Schachter J; Katz U; Mahrer A; Barak D; David LZ; Nusbacher J; Shoenfeld Y
Ann N Y Acad Sci; 2007 Sep; 1110():305-14. PubMed ID: 17911445
[TBL] [Abstract][Full Text] [Related]
22. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Ridolfi L; Fiorentini G; Guida M; Michiara M; Freschi A; Aitini E; Ballardini M; Bichisao E; Ridolfi R;
Melanoma Res; 2009 Apr; 19(2):100-5. PubMed ID: 19262411
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
Gollob JA; Mier JW; Veenstra K; McDermott DF; Clancy D; Clancy M; Atkins MB
Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A; Bross K; Vogt T; Bataille F; Wild P; Berand A; Krause SW; Andreesen R
Cancer; 2004 Nov; 101(10):2247-56. PubMed ID: 15470711
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and statistical evaluation of neuroleptic pimozide].
Glatzel J
Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
[No Abstract] [Full Text] [Related]
27. [Nitrosomethylurea in the treatment of patients with disseminated cutaneous melanoma].
Dement'eva NP; Koroleva LA
Vopr Onkol; 1984; 30(7):51-4. PubMed ID: 6464402
[TBL] [Abstract][Full Text] [Related]
28. Treatment of metastatic malignant melanoma with pimozide.
Taub RN; Baker MA
Lancet; 1979 Mar; 1(8116):605. PubMed ID: 85182
[No Abstract] [Full Text] [Related]
29. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
Mechl Z; Krejcí P
Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial of pimozide.
Anumonye A; Onibuwe-Johnson T; Marinho AA
West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of mitolactol in advanced malignant melanoma.
Murray N; Silver H; Shah A; Wilson K
Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
[No Abstract] [Full Text] [Related]
32. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
[No Abstract] [Full Text] [Related]
33. [Pimozide in non-psychotic elderly patients with behavioural disturbances. An open study (author's transl)].
Fleischlauer J
Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):332-6. PubMed ID: 796855
[TBL] [Abstract][Full Text] [Related]
34. The stress-related emotional lability syndrome. II. A multicentre evaluation of Orap.
Wetzels MH
Acta Psychiatr Belg; 1977; 77(2):277-83. PubMed ID: 906887
[TBL] [Abstract][Full Text] [Related]
35. Mitolactol chemotherapy for malignant melanoma: a phase II study.
Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
[TBL] [Abstract][Full Text] [Related]
36. Pimozide in the treatment of some "social maladjustments" in "personality disorders".
Collard J
Acta Psychiatr Belg; 1979; 79(6):686-703. PubMed ID: 554447
[TBL] [Abstract][Full Text] [Related]
37. Delusions of infestation treated with pimozide: a follow-up study.
Lindskov R; Baadsgaard O
Acta Derm Venereol; 1985; 65(3):267-70. PubMed ID: 2411090
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of mitomycin in disseminated malignant melanoma.
Creagan ET; Edmonson JH; Ahmann DL; Chang M
Cancer Treat Rep; 1985 Dec; 69(12):1451-2. PubMed ID: 4075321
[No Abstract] [Full Text] [Related]
39. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
Torti FM; Porzig KJ; Gandara DR; Volberding P; Mitchell E; Meyers FJ; Kohler M; Gribble M
Cancer Treat Rep; 1984 Dec; 68(12):1509-10. PubMed ID: 6595059
[No Abstract] [Full Text] [Related]
40. Phase II trial of gallium nitrate in patients with advanced malignant melanoma.
Casper ES; Stanton GF; Sordillo PP; Parente R; Michaelson RA; Vinceguerra V
Cancer Treat Rep; 1985 Sep; 69(9):1019-20. PubMed ID: 4028034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
